Page last updated: 2024-08-23

transferrin and Acute Confusional Senile Dementia

transferrin has been researched along with Acute Confusional Senile Dementia in 101 studies

Research

Studies (101)

TimeframeStudies, this research(%)All Research%
pre-19908 (7.92)18.7374
1990's27 (26.73)18.2507
2000's28 (27.72)29.6817
2010's22 (21.78)24.3611
2020's16 (15.84)2.80

Authors

AuthorsStudies
Al Abdulmonem, W; Alhumaydhi, FA; Aljasir, MA; Alsagaby, SA; Alwashmi, ASS; Hassan, MI; Islam, A; Shahwan, M; Shamsi, A1
Chang, X; Lang, M; Peng, Y1
DeLaney, K; Hong, S; Li, G; Li, L; Ma, F; Ma, M; Nair, A; Phetsanthad, A; Yu, Q; Zheng, Z1
Alam, M; DasGupta, D; Hassan, MI; Islam, A; Khan, MS; Shamsi, A; Wang, S; Xue, B1
Atyabi, F; Dinarvand, R; Heydari, M; Khonsari, F; Sharifzadeh, M; Valizadeh, H1
Andrade, S; Loureiro, JA; Pereira, MC; Ramalho, MJ1
Cong, S; Gong, L; Sun, J1
Choi, M; Huynh, PT; Hwang, GB; Jeong, YH; Kim, D; Park, MH; Ryu, J; Vu, HD; Youn, SW; Youn, YJ1
Dos Santos Rodrigues, B; Kanekiyo, T; Singh, J1
Crane, PK; Gonzalez Murcia, JD; Kauwe, JSK; Miller, JB; Mukherjee, S; Staley, L; Vance, E1
Granja, A; Loureiro, JA; Neves, AR; Pereira, MC; Pinheiro, M; Pinheiro, RGR; Reis, S1
Cheng, L; Fu, M; Ju, RJ; Kong, L; Li, HY; Li, XT; Liu, JJ; Ni, YN; Wang, YY; Wu, YT; Xiao, HH; Yang, JX; Yao, YJ1
Ames, D; Ashraf, A; Ashton, NJ; Chatterjee, P; Fripp, J; Goozee, K; Hye, A; Martins, RN; Masters, CL; Rowe, C; Shen, K; So, PW; Villemagne, V1
Arduino, I; Cantore, M; Colabufo, NA; Contino, M; Cutrignelli, A; Denora, N; Franco, M; Iacobazzi, RM; Laquintana, V; Lopalco, A; Lopedota, AA; Luurtsema, G; Perrone, MG; Riganti, C1
Belal, S; Ben Sassi, S; Hentati, F; Jouini, N; Messaoud, T; Nebli, F; Saied, Z1
Boschi, S; Caligiuri, ME; Ficiarà, E; Guiot, C; Munir, Z1
Bailey, DK; Clark, W; Kosman, DJ1
Benyamin, B; Bush, AI; Ferreira, MA; Gordon, SD; Heath, AC; Kloszewska, I; Lovestone, S; Lupton, MK; Madden, PA; Martin, NG; Mecocci, P; Medland, SE; Montgomery, GW; Nyholt, DR; Powell, JF; Proitsi, P; Soininen, H; Tsolaki, M; Vellas, B; Whitfield, JB; Wright, MJ1
Colomina, MT; Peris-Sampedro, F1
Asselta, R; Bosi, C; Franchini, E; Gemmati, D; Greco, A; Longo, G; Ortolani, B; Paraboschi, EM; Secchiero, P; Serino, ML; Seripa, D; Tisato, V; Vigliano, M; Vikram Singh, A; Zauli, G; Zuliani, G; Zurlo, A1
Bi, JZ; Lai, C; Liu, Z; Wang, Y; Wei, Y; Xie, Z; Xu, S; Zhao, C1
Ames, D; Bush, AI; Ellis, KA; Faux, NG; Fowler, CJ; Martins, RN; Masters, CL; Pertile, KK; Rembach, A; Rumble, RL; Trounson, B; Wiley, J1
Chou, PR; Kuo, YC1
Bush, AI; Cherny, RA; Doble, PA; Doecke, JD; Faux, NG; Fowler, CJ; Grimm, R; Hare, DJ; Masters, CL; Rembach, A; Roberts, BR; Volitakis, I1
Chen, ZL; Conti, BA; Renné, T; Strickland, S; Zamolodchikov, D1
Chen, ZL; Fu, J; Gao, JQ; Han, M; Huang, M; Shen, YQ; Wang, XR; Xia, Z1
Antenucci, M; Bucossi, S; Caprara, D; Mariani, S; Molinario, R; Pasqualetti, P; Rongioletti, M; Rossini, PM; Simonelli, I; Siotto, M; Squitti, R; Ventriglia, M1
Arai, H; Fukatsu, M; Furukawa, K; Hashimoto, Y; Hoshi, K; Ishii, R; Ito, H; Kato, T; Kikuchi, A; Miyajima, M; Nollet, K; Takeda, A; Tokuda, T; Ugawa, Y; Yamaguchi, Y; Yoshihara, A1
Gerrish, A; Henson, A; Jones, L; Kidd, EJ; Thomas, RS; Williams, J1
Ahn, HS; Baik, SH; Cha, MY; Hwang, D; Jeong, H; Kim, DK; Kim, HS; Kwon, YW; Lee, YY; Mook-Jung, I; Moon, M; Song, H; Yi, EC1
Antimisiaris, SG; Giannou, AD; Klepetsanis, P; La Ferla, B; Markoutsa, E; Mourtas, S; Nicotra, F; Papadia, K; Salmona, M; Stathopoulos, GT1
Oláh, E; V Oláh, A; Varga, P1
Akatsu, H; Arai, H; Furukawa, K; Hashimoto, Y; Jimbo, D; Kitaura, M; Nakashima, K; Okayama, Y; Taniguchi, M; Urakami, K; Wada-Isoe, K; Wakutani, Y1
Brechlin, P; Cepek, L; Jahn, O; Jesse, S; Kratzin, H; Kretzschmar, HA; Lehnert, S; Mollenhauer, B; Otto, M; Steinacker, P; Wiltfang, J1
Abraham, R; Bertelsen, S; Cruchaga, C; Goate, AM; Harold, D; Hollingworth, P; Kauwe, JS; Lovestone, S; Mayo, K; Morris, JC; Owen, MJ; Williams, J1
Taniguchi, M; Urakami, K1
An, JH; Choi, KH; Jang, SM; Kang, EJ; Kim, CG; Kim, CH; Kim, HJ; Kim, JW1
Alvarez, V; Arias-Vásquez, A; Aulchenko, YS; Barker, R; Belbin, O; Breteler, MM; Brown, K; Combarros, O; Cortina-Borja, M; Coto, E; Deloukas, P; Gwilliam, R; Hammond, N; Heun, R; Ikram, MA; Kehoe, PG; Kölsch, H; Lehmann, DJ; Lehmann, MG; Mateo, I; Morgan, K; Morris, CM; Oulhaj, A; Robson, K; Schuur, M; Smith, AD; van Duijn, CM; Warden, DR; Wilcock, GK1
Bucossi, S; Cassetta, E; Dell'acqua, ML; Giambattistelli, F; Mariani, S; Panetta, V; Rossini, PM; Salustri, C; Siotto, M; Squitti, R; Ventriglia, M; Vernieri, F1
Albahri, Z; Marklová, E; Vališ, M1
Cassetta, E; Cortesi, M; Lupoi, D; Moffa, F; Pasqualetti, P; Polimanti, R; Rossini, PM; Salustri, C; Siotto, M; Squitti, R; Ventriglia, M; Vernieri, F1
de L'escaille, F; Falmagne, JB; Mesbah, K; Taverna, M; Verpillot, R1
Beard, J; Connor, J; Hentze, MW; Menzies, S; Muckenthaler, M; Thompson, K; Torti, FM; Torti, SV; Wood, T1
Ehehalt, R; Haass, C; Keller, P; Simons, K; Thiele, C1
Cassetta, E; Cesaretti, S; Dal Forno, G; Finazzi-Agrò, A; Pasqualetti, P; Pedace, F; Rossini, PM; Squitti, R1
Battaglia, C; Bordoni, R; Castiglioni, B; Consolandi, C; De Bellis, G; Frosini, A; Mezzelani, A; Rizzi, E; Rossi Bernardi, L1
Jin, F; Li, S; Lu, Z; Shi, X; Wan, C; Wang, L; Yang, Z; Zhang, C; Zhang, D; Zhang, P; Zheng, C; Zheng, W1
Bergman, H; Chertkow, HM; Schipper, HM; Yu, HL1
Biunno, I; De Bellis, G; Musicco, M; Zambenedetti, P; Zatta, P1
Combrinck, M; Lehmann, DJ; Livesey, KJ; Merryweather-Clarke, AT; Robson, KJ; Smith, AD; Warden, DR; Wimhurst, VL1
Berman, P; de Villiers, N; Hon, D; MacGregor, P; Potocnik, F; van Rensburg, SJ1
Corder, EH; Galeazzi, L; Galeazzi, R; Giunta, S; Valli, MB1
Eschenbach, SL; Everett, CJ; Gill, JM; Mainous, AG; Wells, BJ1
Baldassini, M; Cassetta, E; Dal Forno, G; Lupoi, D; Moffa, F; Pasqualetti, P; Rossi, L; Rossini, PM; Squitti, R; Vernieri, F1
Gabbiani, C; Gabrielli, S; Mauri, P; Messori, L; van Rensburg, SJ; van Zyl, J; Zatta, P1
Arveiler, B; Commenges, D; Dartigues, JF; Duchêne, F; Iron, A; Letenneur, L; Rondeau, V1
Arriola, E; Blázquez, L; Buiza, C; Cuadrado, E; De Juan, D; Emparanza, JI; Etxeberria, I; Lamet, I; López de Munain, A; Martínez-Lage, P; Otaegui, D; Ruiz-Martínez, J; Sáenz, A; Samaranch, L; Sistiaga, A; Urdaneta, E; Yanguas, J1
Ellis, R; Lehmann, DJ; Merryweather-Clarke, AT; Robson, KJ; Smith, AD; Warden, DR; Wimhurst, VL; Worwood, M1
Elovaara, I1
Chapel, HM; Esiri, MM; Wilcock, GK1
Brickman, CM; Connor, JR; DeMaggio, AJ; Juneau, PL; Kanaley, L; LeWitt, PA; Loeffler, DA; Nguyen, H; Snyder, BS1
Carstens, ME; Potocnik, FC; Taljaard, JJ; van der Spuy, G; van der Walt, BJ; Van Rensburg, SJ1
Oshiro, S1
Clauberg, M; Joshi, JG1
Brickman, CM; DeMaggio, AJ; Finkelman, JH; Juneau, PL; LeWitt, PA; Loeffler, DA; Mashour, GA; Pomara, N1
Aucamp, AK; Carstens, ME; Potocnik, FC; Taljaard, JJ; van Rensburg, SJ1
Armstrong, R; Blair, JA; Corbett, J; Farrar, G; Hodgkins, PS; Prasher, V; Sturman, S1
Beard, JL; Connor, JR; Jones, BC1
Connor, JR; Menzies, SL1
Feldman, H; Jefferies, WA; Kennard, ML; Yamada, T1
Allsop, D; Candy, JM; Edwardson, JA; Hughes, D; Keith, AB; Leake, A; Morris, C; Neill, D; Rima, BK; Taylor, GA1
Danielczyk, W; Fischer, P; Götz, ME; Gsell, W; Riederer, P1
Ihara, Y; Imagawa, M; Namekata, K; Ohta, S; Oyama, F; Terashi, A1
Adolfsson, R; Beckman, L; Beckman, LE; Sikström, C; Van Landeghem, GF1
Funato, H; Ihara, Y; Ishikawa, K; Kusui, K; Namekata, K; Ohkoshi, N; Okeda, R; Tamaoka, A; Yoshimura, M1
Ebneth, A; Godemann, R; Illenberger, S; Mandelkow, E; Stamer, K; Trinczek, B1
Ohta, S1
De Villiers, JN; Kotze, MJ; Potocnik, FC; Taljaard, JJ; van Rensburg, SJ1
Cai, Y; Kawahara, M; Kitajima, S; Kuroda, Y; Oshiro, S; Shirao, M; Zhang, C1
Berman, PA; Potocnik, FC; Taljaard, JJ; van Rensburg, SJ1
Jhoo, JH; Kim, KW; Lee, DY; Lee, JH; Lee, KU; Woo, JI; Youn, JY1
Li, XB; Liao, GS; Shu, YY; Tang, SX; Zhang, CY1
Jhoo, JH; Kim, KW; Lee, DY; Lee, JH; Lee, KU; Woo, JI; Youn, JC; Youn, JY1
Ballard, CG; Edwardson, JA; Hussain, RI; Morris, CM1
Angelopoulos, C; Blesa, R; Bufill, E; Lleó, A; Oliva, R; Pastor-Rubio, P; Villa, M1
Altmann, P; Blair, JA; Farrar, G; Hodgkins, P1
Bilinski, H; Horvath, L; Trbojevic-Cepe, M1
Corrigan, FM; Crichton, JS; Skinner, ER; Van Rhijn, AG; Ward, NI1
Beard, JL; Connor, JR; Fine, RE; Mufson, EJ; Snyder, BS1
Connor, JR; Menzies, SL; Mufson, EJ; St Martin, SM1
Altmann, P; Blair, JA; Corbett, J; Farrar, G; Ghose, B; Lejeune, J; Prasher, V; Welch, S; Wychrij, O1
Brammer, M; Burns, A; Förstl, H; Levy, R; Richmond, S1
Candy, JM; Edwardson, JA; Keith, AB; Morris, CM; Pullen, RG; Taylor, G1
Blair, JA; Cowburn, JD1
Cuny, G; Dubois, F; Jeandel, C; Nabet-Belleville, F; Nicolas, MB; Penin, F1
Bohmont, CW; Duguid, JR; Liu, NG; Tourtellotte, WW1
Ganrot, PO1
Elovaara, I; Erkinjuntti, T; Palo, J; Sulkava, R1
Elovaara, I; Erkinjuntti, T; Icén, A; Palo, J1

Reviews

11 review(s) available for transferrin and Acute Confusional Senile Dementia

ArticleYear
Iron Homeostasis Disorder and Alzheimer's Disease.
    International journal of molecular sciences, 2021, Nov-18, Volume: 22, Issue:22

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Antigens, CD; Brain; Cation Transport Proteins; Gene Expression Regulation; Hepatocytes; Homeostasis; Humans; Intestinal Absorption; Iron; Iron Overload; Liver; Macrophages; Receptors, Transferrin; Transcription Factors; Transferrin; Transfusion Reaction

2021
Levels of iron and iron-related proteins in Alzheimer's disease: A systematic review and meta-analysis.
    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2023, Volume: 80

    Topics: Alzheimer Disease; Ferritins; Haptoglobins; Hepcidins; Humans; Iron; Lactoferrin; Transferrin

2023
Alteration of Iron Concentration in Alzheimer's Disease as a Possible Diagnostic Biomarker Unveiling Ferroptosis.
    International journal of molecular sciences, 2021, Apr-25, Volume: 22, Issue:9

    Topics: Alzheimer Disease; Biomarkers; Brain; Ceruloplasmin; Ferritins; Ferroptosis; Humans; Iron; Iron Metabolism Disorders; Magnetic Resonance Imaging; Neurodegenerative Diseases; Oxidative Stress; Transferrin

2021
Aluminum and Alzheimer's Disease.
    Advances in neurobiology, 2017, Volume: 18

    Topics: Aluminum; Alzheimer Disease; Environmental Exposure; Glucose; Humans; Iron; Neurotoxicity Syndromes; Oxidative Stress; Sex Factors; Transferrin

2017
Meta-analysis on the association between the TF gene rs1049296 and AD.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2013, Volume: 40, Issue:5

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Bias; Databases, Bibliographic; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Male; Meta-Analysis as Topic; Middle Aged; Polymorphism, Single Nucleotide; Risk; Transferrin

2013
[Biochemical alterations in patients with Down syndrome].
    Orvosi hetilap, 2008, Jun-29, Volume: 149, Issue:26

    Topics: Acetylglucosaminidase; Adult; Alzheimer Disease; Antioxidants; Bilirubin; Blood Proteins; Cystathionine beta-Synthase; Disease Progression; Down Syndrome; Ferritins; Folic Acid; Homocysteine; Humans; Learning; Nootropic Agents; Quality of Life; S100 Proteins; Serum Albumin; Superoxide Dismutase; Transferrin; Vitamin B 12

2008
[Early diagnostic biomarker for Alzheimer's disease now and in the future].
    Rinsho shinkeigaku = Clinical neurology, 2009, Volume: 49, Issue:11

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Diagnosis, Differential; Early Diagnosis; Humans; Neuropsychological Tests; tau Proteins; Transferrin

2009
Contribution of CE to the analysis of protein or peptide biomarkers.
    Methods in molecular biology (Clifton, N.J.), 2013, Volume: 984

    Topics: alpha-Fetoproteins; Alzheimer Disease; Amyloid beta-Protein Precursor; Biomarkers; Chromatography, Affinity; Electrophoresis, Capillary; Humans; Limit of Detection; Peptides; Transferrin

2013
[A new inducible transferrin-independent iron uptake system involved with aluminum accumulation in the brain of patients with Alzheimer's disease].
    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1995, Volume: 40, Issue:11

    Topics: Aluminum; Alzheimer Disease; Animals; Biological Transport; Brain; Hemochromatosis; Humans; Iron; Transferrin

1995
Iron in the brain.
    Nutrition reviews, 1993, Volume: 51, Issue:6

    Topics: Adult; Aging; Alzheimer Disease; Animals; Brain; Child; Child, Preschool; Ferritins; Humans; Infant; Iron; Multiple Sclerosis; Parkinson Disease; Rats; Receptors, Transferrin; Transferrin

1993
Metabolism and possible health effects of aluminum.
    Environmental health perspectives, 1986, Volume: 65

    Topics: Actin Cytoskeleton; Aluminum; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Aneuploidy; Animals; Autoimmune Diseases; Beryllium; Biological Transport; Bone and Bones; Brain; Cations; Cell Division; Cells; Chromium; Connective Tissue; Cytoplasm; DNA; Down Syndrome; Encephalitis; Erythrocytes; Feces; Gallium; Humans; Hypersensitivity; Immunity, Cellular; Indium; Intestinal Absorption; Intestinal Mucosa; Lung; Membrane Lipids; Microtubules; Muscular Dystrophies; Nondisjunction, Genetic; Osteomalacia; Parkinson Disease; Renal Dialysis; Scandium; Tissue Distribution; Transferrin; Yttrium; Zirconium

1986

Trials

1 trial(s) available for transferrin and Acute Confusional Senile Dementia

ArticleYear
Transferrin C2, metal binding and Alzheimer's disease.
    Neuroreport, 1998, Jan-26, Volume: 9, Issue:2

    Topics: Aluminum; Alzheimer Disease; Free Radicals; Humans; Iron; Metals; Protein Binding; Transferrin

1998

Other Studies

89 other study(ies) available for transferrin and Acute Confusional Senile Dementia

ArticleYear
Spectroscopic, calorimetric and in silico insight into the molecular interactions of Memantine with human transferrin: Implications of Alzheimer's drugs.
    International journal of biological macromolecules, 2021, Nov-01, Volume: 190

    Topics: Alzheimer Disease; Calorimetry; Computer Simulation; Fluorescence; Humans; Hydrogen Bonding; Memantine; Molecular Docking Simulation; Molecular Dynamics Simulation; Principal Component Analysis; Protein Conformation; Thermodynamics; Transferrin

2021
Native Ion Mobility-Mass Spectrometry-Enabled Fast Structural Interrogation of Labile Protein Surface Modifications at the Intact Protein Level.
    Analytical chemistry, 2022, 02-01, Volume: 94, Issue:4

    Topics: Alzheimer Disease; Glycoproteins; Humans; Mass Spectrometry; Sialic Acids; Transferrin

2022
Investigating binding mechanism of thymoquinone to human transferrin, targeting Alzheimer's disease therapy.
    Journal of cellular biochemistry, 2022, Volume: 123, Issue:8

    Topics: Alzheimer Disease; Benzoquinones; Humans; Iron; Molecular Docking Simulation; Transferrin

2022
Transferrin decorated-nanostructured lipid carriers (NLCs) are a promising delivery system for rapamycin in Alzheimer's disease: An in vivo study.
    Biomaterials advances, 2022, Volume: 137

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Lipids; Mammals; Memory Disorders; Rats; Sirolimus; TOR Serine-Threonine Kinases; Transferrin

2022
Transferrin-functionalized liposomes loaded with vitamin VB12 for Alzheimer's disease therapy.
    International journal of pharmaceutics, 2022, Oct-15, Volume: 626

    Topics: Alzheimer Disease; Blood-Brain Barrier; Delayed-Action Preparations; Humans; Liposomes; Nanoparticles; Transferrin; Vitamin B 12; Vitamins

2022
Transferrin-Conjugated Melittin-Loaded L-Arginine-Coated Iron Oxide Nanoparticles for Mitigating Beta-Amyloid Pathology of the 5XFAD Mouse Brain.
    International journal of molecular sciences, 2023, Oct-06, Volume: 24, Issue:19

    Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Brain; Disease Models, Animal; Magnetic Iron Oxide Nanoparticles; Melitten; Mice; Mice, Transgenic; Plaque, Amyloid; Transferrin

2023
ApoE-2 Brain-Targeted Gene Therapy Through Transferrin and Penetratin Tagged Liposomal Nanoparticles.
    Pharmaceutical research, 2019, Sep-16, Volume: 36, Issue:11

    Topics: Alzheimer Disease; Animals; Apolipoprotein E2; Blood-Brain Barrier; Cell-Penetrating Peptides; Female; Genetic Therapy; Humans; Liposomes; Male; Mice, Inbred C57BL; Nanoparticles; Transferrin

2019
Failure to detect synergy between variants in transferrin and hemochromatosis and Alzheimer's disease in large cohort.
    Neurobiology of aging, 2020, Volume: 89

    Topics: Alzheimer Disease; Cohort Studies; Epistasis, Genetic; Genetic Association Studies; Genetic Predisposition to Disease; Genetic Variation; Hemochromatosis; Hemochromatosis Protein; Humans; Negative Results; Oxidative Stress; Risk; Transferrin

2020
Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2020, May-30, Volume: 148

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Blood-Brain Barrier; Brain; Cell Line; Cell Survival; Drug Carriers; Drug Delivery Systems; Endothelial Cells; Humans; Lipids; Nanoparticles; Particle Size; Quercetin; Transferrin

2020
Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer's Disease-Related Pathology in APP/PS-1 Mice.
    International journal of nanomedicine, 2020, Volume: 15

    Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Brain; Cell Line; Coumarins; Humans; Liposomes; Mice, Transgenic; Neurons; Neuroprotective Agents; Polyethylene Glycols; Presenilin-1; Rats, Sprague-Dawley; Tissue Distribution; Transferrin

2020
Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer's disease pathology.
    Alzheimer's research & therapy, 2020, 06-09, Volume: 12, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Australia; Cognitive Dysfunction; Hemopexin; Humans; Proteomics; Transferrin

2020
Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease.
    International journal of pharmaceutics, 2020, Dec-15, Volume: 591

    Topics: Alzheimer Disease; Amyloid beta-Peptides; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Blood-Brain Barrier; Brain; Endothelial Cells; Humans; Lipids; Neoplasm Proteins; Transferrin

2020
Impacts of Iron Metabolism Dysregulation on Alzheimer's Disease.
    Journal of Alzheimer's disease : JAD, 2021, Volume: 80, Issue:4

    Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Ceruloplasmin; Female; Humans; Iron; Male; Middle Aged; Transferrin

2021
The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells.
    PloS one, 2021, Volume: 16, Issue:7

    Topics: Alzheimer Disease; Animals; Antigens, CD; Biological Transport; Blood-Brain Barrier; Brain; Cell Membrane; Ceruloplasmin; Endothelial Cells; Ferritins; Humans; Iron; Iron Chelating Agents; Membrane Proteins; Microcirculation; Parkinson Disease; Quinazolinones; Receptors, Transferrin; Transferrin

2021
No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease.
    Journal of Alzheimer's disease : JAD, 2017, Volume: 59, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoproteins E; Cohort Studies; Community Health Planning; Female; Ferritins; Genetic Association Studies; Humans; Iron; Male; Meta-Analysis as Topic; Middle Aged; Polymorphism, Single Nucleotide; Transferrin

2017
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.
    PloS one, 2018, Volume: 13, Issue:3

    Topics: Aged; Aged, 80 and over; Alleles; Alzheimer Disease; Apolipoproteins E; Cation Transport Proteins; Cognitive Dysfunction; Dementia, Vascular; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Hemochromatosis Protein; Hepcidins; Homeostasis; Humans; Iron; Male; Mental Status and Dementia Tests; Polymorphism, Single Nucleotide; Risk Factors; Transferrin

2018
An anemia of Alzheimer's disease.
    Molecular psychiatry, 2014, Volume: 19, Issue:11

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anemia; Australia; Cognitive Dysfunction; Cross-Sectional Studies; Female; Folic Acid; Hemoglobins; Humans; Iron; Male; Middle Aged; Prospective Studies; Risk Factors; Transferrin

2014
Neuroprotection against degeneration of sk-N-mc cells using neuron growth factor-encapsulated liposomes with surface cereport and transferrin.
    Journal of pharmaceutical sciences, 2014, Volume: 103, Issue:8

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Astrocytes; Bradykinin; Brain; Cell Line; Cell Survival; Drug Delivery Systems; Endothelial Cells; Humans; Liposomes; Nerve Growth Factors; Neuroprotective Agents; Peptide Fragments; Transferrin

2014
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation.
    ACS chemical neuroscience, 2015, Mar-18, Volume: 6, Issue:3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Australia; Case-Control Studies; Chromatography, Gel; Female; Humans; Iron; Male; Mass Spectrometry; Middle Aged; Plasma; Prospective Studies; Transferrin

2015
Activation of the factor XII-driven contact system in Alzheimer's disease patient and mouse model plasma.
    Proceedings of the National Academy of Sciences of the United States of America, 2015, Mar-31, Volume: 112, Issue:13

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Animals; Biomarkers; Case-Control Studies; Dementia; Disease Models, Animal; Disease Progression; Factor XII; Factor XIIa; Female; Humans; Inflammation; Kallikreins; Kininogens; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron, Transmission; Peptide Fragments; Transferrin

2015
Transferrin-modified liposome promotes α-mangostin to penetrate the blood-brain barrier.
    Nanomedicine : nanotechnology, biology, and medicine, 2016, Volume: 12, Issue:2

    Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Brain; Cell Line; Drug Delivery Systems; Garcinia mangostana; Liposomes; Mice; Neuroprotective Agents; Rats, Sprague-Dawley; Transferrin; Xanthones

2016
Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.
    Journal of Alzheimer's disease : JAD, 2016, Volume: 50, Issue:4

    Topics: Aged; Alzheimer Disease; Apolipoprotein E4; Area Under Curve; Biomarkers; Blood Chemical Analysis; Ceruloplasmin; Copper; Female; Genotype; Genotyping Techniques; Humans; Logistic Models; Male; Multivariate Analysis; Prognosis; Risk; ROC Curve; Sensitivity and Specificity; Transferrin

2016
Subgroup differences in 'brain-type' transferrin and α-synuclein in Parkinson's disease and multiple system atrophy.
    Journal of biochemistry, 2016, Volume: 160, Issue:2

    Topics: alpha-Synuclein; Alzheimer Disease; Female; Humans; Male; Parkinson Disease; Protein Isoforms; Transferrin

2016
Decreasing the expression of PICALM reduces endocytosis and the activity of β-secretase: implications for Alzheimer's disease.
    BMC neuroscience, 2016, 07-18, Volume: 17, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Blotting, Western; Brain; Cell Line, Tumor; Clathrin Heavy Chains; Endocytosis; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunohistochemistry; Monomeric Clathrin Assembly Proteins; Peptide Fragments; Protein Isoforms; RNA, Messenger; RNA, Small Interfering; Transferrin

2016
Protein-Induced Pluripotent Stem Cells Ameliorate Cognitive Dysfunction and Reduce Aβ Deposition in a Mouse Model of Alzheimer's Disease.
    Stem cells translational medicine, 2017, Volume: 6, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Behavior, Animal; Brain; Cell Differentiation; Cognitive Dysfunction; Disease Models, Animal; Induced Pluripotent Stem Cells; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Oligodendroglia; Plaque, Amyloid; Proteome; Stem Cell Transplantation; Transferrin; Up-Regulation

2017
Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof-of-concept.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2017, Apr-01, Volume: 101

    Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Biological Transport; Blood-Brain Barrier; Brain; Cells, Cultured; Curcumin; Endothelial Cells; Humans; Liposomes; Transferrin

2017
Sugar chains of cerebrospinal fluid transferrin as a new biological marker of Alzheimer's disease.
    Dementia and geriatric cognitive disorders, 2008, Volume: 26, Issue:2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Female; Glycosylation; Humans; Isoelectric Focusing; Male; Peptide Fragments; Phosphorylation; tau Proteins; Tauopathies; Transferrin; Wheat Germ Agglutinins

2008
Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
    Proteomics, 2008, Volume: 8, Issue:20

    Topics: 14-3-3 Proteins; Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Creutzfeldt-Jakob Syndrome; Diagnosis, Differential; Electrophoresis, Gel, Two-Dimensional; Female; Gelsolin; Humans; Lewy Body Disease; Male; Middle Aged; Neurodegenerative Diseases; Prealbumin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; tau Proteins; Transferrin

2008
Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease.
    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2010, Jun-05, Volume: 153B, Issue:4

    Topics: Aged; Alleles; Alzheimer Disease; Apolipoproteins E; Case-Control Studies; Female; Genotype; Hemochromatosis; Humans; Iron; Male; Multicenter Studies as Topic; Polymorphism, Single Nucleotide; Risk; Risk Factors; Transferrin

2010
Control of transferrin expression by β-amyloid through the CP2 transcription factor.
    The FEBS journal, 2010, Volume: 277, Issue:19

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Base Sequence; Binding Sites; Cloning, Molecular; Conserved Sequence; DNA Primers; DNA-Binding Proteins; Gene Expression Regulation; Genes, Reporter; Genetic Vectors; Humans; Luciferases; Plasmids; Promoter Regions, Genetic; Protein Binding; Transcription Factors; Transcription, Genetic; Transfection; Transferrin; Up-Regulation

2010
Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project.
    Neurobiology of aging, 2012, Volume: 33, Issue:1

    Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Apolipoprotein E4; Epistasis, Genetic; Female; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Iron Chelating Agents; Iron Overload; Male; Membrane Proteins; Oxidative Stress; Risk; Transferrin

2012
Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease.
    Neurobiology of aging, 2012, Volume: 33, Issue:8

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Causality; Comorbidity; Female; Genetic Predisposition to Disease; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Iron; Italy; Liver Diseases; Male; Membrane Proteins; Mutation; Polymorphism, Single Nucleotide; Prevalence; Risk Factors; Transferrin

2012
Microheterogeneity of some serum glycoproteins in neurodegenerative diseases.
    Journal of the neurological sciences, 2012, Mar-15, Volume: 314, Issue:1-2

    Topics: Adult; Age Factors; Aged; Aging; Alleles; alpha 1-Antitrypsin; Alzheimer Disease; Apolipoprotein C-III; Apolipoproteins E; Child; Czech Republic; Dementia, Vascular; Female; Gene Frequency; Glycoproteins; Glycosylation; Humans; Isoelectric Focusing; Male; Middle Aged; Neurodegenerative Diseases; Parkinson Disease; Sex Factors; Transferrin

2012
Metal-score as a potential non-invasive diagnostic test for Alzheimer's disease.
    Current Alzheimer research, 2013, Volume: 10, Issue:2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Antioxidants; Apolipoprotein E4; Ceruloplasmin; Copper; Dementia, Vascular; Female; Humans; Iron; Male; Metals; Middle Aged; ROC Curve; Transferrin

2013
Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.
    Journal of neuroscience research, 2003, Jan-01, Volume: 71, Issue:1

    Topics: Alzheimer Disease; Animals; Apoferritins; bcl-2-Associated X Protein; Brain; Caspase 3; Caspases; Cation Transport Proteins; Cerebellar Cortex; Cerebellum; Ceruloplasmin; Corpus Striatum; Disease Models, Animal; Ferritins; Gene Expression Profiling; Gene Targeting; Genotype; Heme Oxygenase (Decyclizing); Hippocampus; Immunochemistry; Iron; Iron Deficiencies; Iron-Binding Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oxidative Stress; Parkinson Disease; Phenotype; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Transferrin; Superoxide Dismutase; Transferrin

2003
Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts.
    The Journal of cell biology, 2003, Jan-06, Volume: 160, Issue:1

    Topics: Adenoviridae; Alkaline Phosphatase; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Biotin; Cell Line; Cholesterol; Cross-Linking Reagents; Detergents; Endocytosis; Membrane Microdomains; Mice; Microscopy, Fluorescence; Models, Biological; Precipitin Tests; Receptors, Transferrin; Time Factors; Transfection; Transferrin; Tumor Cells, Cultured

2003
Elevation of serum copper levels discriminates Alzheimer's disease from vascular dementia.
    Neurology, 2003, Jun-24, Volume: 60, Issue:12

    Topics: Aged; Alzheimer Disease; Antioxidants; Cations, Divalent; Copper; Dementia, Vascular; Diagnosis, Differential; Female; Humans; Iron; Male; Oxidation-Reduction; Peroxides; Sensitivity and Specificity; Transferrin

2003
Apolipoprotein E and transferrin genotyping by ligation detection reaction and universal array.
    Clinical chemistry, 2003, Volume: 49, Issue:9

    Topics: Alzheimer Disease; Apolipoproteins E; Genotype; Humans; Oligonucleotide Array Sequence Analysis; Polymorphism, Genetic; Sensitivity and Specificity; Transferrin

2003
Association study between late-onset Alzheimer's disease and the transferrin gene polymorphisms in Chinese.
    Neuroscience letters, 2003, Oct-09, Volume: 349, Issue:3

    Topics: Age Factors; Aged; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Brain; Brain Chemistry; China; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Male; Polymorphism, Genetic; Risk Factors; Transferrin

2003
Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma.
    Proteomics, 2003, Volume: 3, Issue:11

    Topics: alpha 1-Antitrypsin; Alzheimer Disease; Chromatography, Affinity; Concanavalin A; Electrophoresis, Gel, Two-Dimensional; Glycoproteins; Hemopexin; Heparin; Humans; Oxidation-Reduction; Phenylhydrazines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transferrin

2003
Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians.
    Journal of Alzheimer's disease : JAD, 2003, Volume: 5, Issue:6

    Topics: Aged; Aged, 80 and over; Alleles; Alzheimer Disease; Apolipoproteins E; Diagnostic and Statistical Manual of Mental Disorders; Female; Globus Pallidus; Humans; Iron; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Transferrin; White People

2003
Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.
    Journal of medical genetics, 2004, Volume: 41, Issue:4

    Topics: Aged; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Case-Control Studies; Cognition Disorders; Female; Genetic Predisposition to Disease; Genotype; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Iron; Male; Membrane Proteins; Oxidative Stress; Polymorphism, Genetic; Transferrin

2004
5- and 6-glycosylation of transferrin in patients with Alzheimer's disease.
    Metabolic brain disease, 2004, Volume: 19, Issue:1-2

    Topics: Alcoholism; Alzheimer Disease; Free Radicals; Glycosylation; Heterozygote; Homozygote; Humans; Isoelectric Focusing; N-Acetylneuraminic Acid; Oxidation-Reduction; Transferrin

2004
Transferrin neutralization of amyloid beta 25-35 cytotoxicity.
    Clinica chimica acta; international journal of clinical chemistry, 2004, Volume: 350, Issue:1-2

    Topics: Adolescent; Adult; Alzheimer Disease; Amyloid beta-Peptides; Congo Red; Drug Interactions; Erythrocytes; Hemolysis; Humans; Peptide Fragments; Spectrophotometry; Transferrin

2004
Cholesterol, transferrin saturation, and the development of dementia and Alzheimer's disease: results from an 18-year population-based cohort.
    Family medicine, 2005, Volume: 37, Issue:1

    Topics: Adult; Aged; Alzheimer Disease; Cholesterol; Cohort Studies; Dementia; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nutrition Surveys; Proportional Hazards Models; Risk Factors; Transferrin

2005
Excess of serum copper not related to ceruloplasmin in Alzheimer disease.
    Neurology, 2005, Mar-22, Volume: 64, Issue:6

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Biomarkers; Ceruloplasmin; Copper; Encephalitis; Female; Humans; Inflammation Mediators; Male; Middle Aged; Peroxides; Predictive Value of Tests; Transferrin

2005
The C2 variant of human serum transferrin retains the iron binding properties of the native protein.
    Biochimica et biophysica acta, 2005, Sep-25, Volume: 1741, Issue:3

    Topics: Alzheimer Disease; Amino Acid Substitution; Chromatography, Liquid; Circular Dichroism; Humans; Hydrogen-Ion Concentration; Iron; Polymorphism, Single Nucleotide; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Transferrin

2005
Analysis of the effect of aluminum in drinking water and transferrin C2 allele on Alzheimer's disease.
    European journal of neurology, 2006, Volume: 13, Issue:9

    Topics: Aged; Aged, 80 and over; Alleles; Aluminum; Alzheimer Disease; Apolipoproteins E; Case-Control Studies; Chi-Square Distribution; Cohort Studies; Environmental Exposure; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Logistic Models; Male; Neurotoxins; Polymorphism, Genetic; Retrospective Studies; Risk; Transferrin

2006
Genes related to iron metabolism and susceptibility to Alzheimer's disease in Basque population.
    Neurobiology of aging, 2007, Volume: 28, Issue:12

    Topics: Aged; Alzheimer Disease; Comorbidity; Female; Genetic Predisposition to Disease; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Iron Metabolism Disorders; Male; Membrane Proteins; Prevalence; Risk Assessment; Risk Factors; Spain; Transferrin

2007
Iron genes, iron load and risk of Alzheimer's disease.
    Journal of medical genetics, 2006, Volume: 43, Issue:10

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E4; Cohort Studies; Female; Genotype; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Iron; Iron Overload; Male; Membrane Proteins; Middle Aged; Polymorphism, Genetic; Risk Factors; Transferrin

2006
Proteins in serum and cerebrospinal fluid in demented patients with Down's syndrome.
    Acta neurologica Scandinavica, 1984, Volume: 69, Issue:5

    Topics: Adult; Alzheimer Disease; Blood Proteins; Cerebrospinal Fluid Proteins; Dementia; Down Syndrome; Female; Haptoglobins; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; Prealbumin; Serum Albumin; Transferrin

1984
Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease.
    Journal of clinical pathology, 1984, Volume: 37, Issue:6

    Topics: Aged; alpha 1-Antitrypsin; Alzheimer Disease; Cerebrospinal Fluid Proteins; Electrophoresis; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulins; Middle Aged; tau Proteins; Transferrin

1984
Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions.
    Journal of neurochemistry, 1995, Volume: 65, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cadaver; Female; Humans; Iron; Male; Middle Aged; Osmolar Concentration; Parkinson Disease; Reference Values; Transferrin

1995
Transferrin C2 and Alzheimer's disease: another piece of the puzzle found?
    Medical hypotheses, 1995, Volume: 44, Issue:4

    Topics: Aluminum; Alzheimer Disease; Endocytosis; Free Radicals; Genetic Variation; Humans; Hydroxyl Radical; Immune System; Iron; Lipid Peroxidation; Microglia; Models, Biological; Receptors, Transferrin; Transferrin

1995
Regulation of serine protease activity by aluminum: implications for Alzheimer disease.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Feb-01, Volume: 90, Issue:3

    Topics: Aluminum; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aprotinin; Brain; Chymotrypsin; Enzyme Activation; Humans; Hydrogen-Ion Concentration; Serine Endopeptidases; Transferrin

1993
Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease.
    Alzheimer disease and associated disorders, 1994,Fall, Volume: 8, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Ceruloplasmin; Dementia; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Parkinson Disease; Transferrin

1994
Increased frequency of the transferrin C2 subtype in Alzheimer's disease.
    Neuroreport, 1993, Sep-10, Volume: 4, Issue:11

    Topics: Aluminum; Alzheimer Disease; Electrophoresis, Polyacrylamide Gel; Free Radicals; Heterozygote; Homozygote; Humans; Iron; Isoelectric Focusing; South Africa; Transferrin

1993
Reduced transferrin binding in Down syndrome: a route to senile plaque formation and dementia.
    Neuroreport, 1993, Oct-25, Volume: 5, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Aging; Alzheimer Disease; Child; Child, Preschool; Dementia; Down Syndrome; Female; Humans; Male; Middle Aged; Organometallic Compounds; Receptors, Transferrin; Transferrin

1993
Cellular management of iron in the brain.
    Journal of the neurological sciences, 1995, Volume: 134 Suppl

    Topics: Alzheimer Disease; Brain; Brain Chemistry; Ferritins; Humans; Immunohistochemistry; Iron; Oxidation-Reduction; Receptors, Transferrin; Transferrin

1995
Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease.
    Nature medicine, 1996, Volume: 2, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Carrier Proteins; Female; Humans; Iron-Binding Proteins; Male; Middle Aged; Transferrin; Transferrin-Binding Proteins

1996
Effect of aluminium on expression and processing of amyloid precursor protein.
    Journal of neuroscience research, 1996, Nov-15, Volume: 46, Issue:4

    Topics: Aluminum; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Apoproteins; Blotting, Northern; Blotting, Western; Brain Chemistry; Gene Expression Regulation; Humans; Molecular Weight; Nerve Tissue Proteins; Neuroblastoma; Protein Processing, Post-Translational; Rats; RNA, Messenger; Transferrin; Tumor Cells, Cultured

1996
Blood transferrin and ferritin in Alzheimer's disease.
    Life sciences, 1997, Volume: 60, Issue:25

    Topics: Aged; Alzheimer Disease; Ferritins; Humans; Longitudinal Studies; Prospective Studies; Transferrin

1997
Association of transferrin C2 allele with late-onset Alzheimer's disease.
    Human genetics, 1997, Volume: 101, Issue:2

    Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Alleles; Alzheimer Disease; Apolipoproteins E; Gene Frequency; Genetic Variation; Homozygote; Humans; Middle Aged; Transferrin

1997
Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease.
    The American journal of pathology, 1998, Volume: 152, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Cerebral Cortex; Female; Genotype; Hippocampus; Humans; Immunoenzyme Techniques; Immunohistochemistry; Male; Middle Aged; Protein Processing, Post-Translational; Transferrin

1998
Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease.
    The Journal of cell biology, 1998, Nov-02, Volume: 143, Issue:3

    Topics: Alzheimer Disease; Animals; Biological Transport; Cell Size; Centrosome; CHO Cells; Cricetinae; Docetaxel; Dyneins; Endoplasmic Reticulum; Gene Expression; Intermediate Filament Proteins; Kinesins; Microinjections; Mitochondria; Nocodazole; Paclitaxel; tau Proteins; Taxoids; Transferrin; Tumor Cells, Cultured

1998
[Senile dementia of Alzheimer type].
    Nihon Ika Daigaku zasshi, 1999, Volume: 66, Issue:5

    Topics: Adenosine Triphosphate; Aged; Alleles; Alzheimer Disease; Amyloid beta-Protein Precursor; Apolipoproteins E; Apoptosis; Humans; Mitochondria; Mutation; Risk Factors; Transferrin

1999
Earlier age of onset of Alzheimer's disease in patients with both the transferrin C2 and apolipoprotein E-epsilon 4 alleles.
    Annals of the New York Academy of Sciences, 2000, Volume: 903

    Topics: Age of Onset; Aged; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Dementia, Vascular; DNA; Humans; Middle Aged; Polymerase Chain Reaction; Protein Isoforms; Reference Values; Transferrin

2000
Glial cells contribute more to iron and aluminum accumulation but are more resistant to oxidative stress than neuronal cells.
    Biochimica et biophysica acta, 2000, Nov-15, Volume: 1502, Issue:3

    Topics: Aluminum; Alzheimer Disease; Animals; Calcium; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Gene Expression Regulation; Iron; Neuroglia; Neurons; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Transferrin; RNA, Messenger; Temperature; Transferrin

2000
Glycosylation of transferrin in Alzheimer's disease and alcohol-induced dementia.
    Metabolic brain disease, 2000, Volume: 15, Issue:4

    Topics: Adult; Alcoholism; Alzheimer Disease; Glycosylation; Humans; Male; N-Acetylneuraminic Acid; Oligosaccharides; Transferrin

2000
Transferrin C2 variant does not confer a risk for Alzheimer's disease in Koreans.
    Neuroscience letters, 2001, Jul-27, Volume: 308, Issue:1

    Topics: Age Factors; Aged; Alzheimer Disease; Apolipoproteins E; Chromosome Mapping; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Korea; Linkage Disequilibrium; Male; Polymorphism, Genetic; Sex Factors; Transferrin

2001
Pharmacological actions of nerve growth factor-transferrin conjugate on the central nervous system.
    Journal of natural toxins, 2001, Volume: 10, Issue:4

    Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Drug Carriers; Injections, Intravenous; Maze Learning; Memory; Mice; Models, Animal; Nerve Growth Factor; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra; Transferrin

2001
Neither the butyrylcholinesterase K variant nor transferrin C2 variant confers a risk for Alzheimer's disease in Koreans.
    Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:10

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Butyrylcholinesterase; Chi-Square Distribution; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Haplotypes; Humans; Korea; Linkage Disequilibrium; Male; Transferrin

2001
Transferrin gene polymorphism in Alzheimer's disease and dementia with Lewy bodies in humans.
    Neuroscience letters, 2002, Jan-04, Volume: 317, Issue:1

    Topics: Aged; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Brain; DNA Mutational Analysis; Free Radicals; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Iron; Lewy Body Disease; Middle Aged; Neurons; Oxidative Stress; Polymorphism, Genetic; Transferrin

2002
Transferrin C2 allele, haemochromatosis gene mutations, and risk for Alzheimer's disease.
    Journal of neurology, neurosurgery, and psychiatry, 2002, Volume: 72, Issue:6

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Gene Frequency; Hemochromatosis; Humans; Male; Middle Aged; Risk Factors; Transferrin

2002
Gallium (aluminium) transferrin binding in Alzheimer's disease.
    Lancet (London, England), 1992, Feb-01, Volume: 339, Issue:8788

    Topics: Aluminum; Alzheimer Disease; Gallium Radioisotopes; Humans; Research Design; Transferrin

1992
Precipitation and characterization of an aluminosilicate from AlCl3-Na2SiO3-HCl in serum, of interest for Alzheimer disease.
    Clinical chemistry, 1992, Volume: 38, Issue:10

    Topics: Aluminum; Aluminum Chloride; Aluminum Compounds; Aluminum Silicates; Alzheimer Disease; Anions; Blood Proteins; Brain; Cations; Chemical Precipitation; Chlorides; Electrophoresis, Polyacrylamide Gel; Humans; Immunoglobulin G; Magnetic Resonance Spectroscopy; Serum Albumin; Silicates; Silicic Acid; Spectrophotometry, Infrared; Transferrin; X-Ray Diffraction

1992
Transferrin, cholesterol and aluminium in Alzheimer's disease.
    Clinica chimica acta; international journal of clinical chemistry, 1992, Oct-15, Volume: 211, Issue:1-2

    Topics: Aged; Aged, 80 and over; Aluminum; Alzheimer Disease; Cholesterol; Female; Humans; Male; Transferrin

1992
Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease.
    Journal of neuroscience research, 1992, Volume: 31, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Blotting, Western; Brain Chemistry; Female; Ferritins; Homeostasis; Humans; Iron; Male; Middle Aged; Transferrin

1992
A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains.
    Journal of neuroscience research, 1992, Volume: 31, Issue:1

    Topics: Alzheimer Disease; Brain Chemistry; Cerebral Cortex; Ferritins; Hippocampus; Humans; Iron; Neurofibrillary Tangles; Transferrin

1992
Transferrin-gallium binding in Alzheimer's disease.
    Lancet (London, England), 1991, Nov-30, Volume: 338, Issue:8779

    Topics: Aged; Aluminum; Alzheimer Disease; Brain; Female; Gallium Radioisotopes; Humans; Iron Radioisotopes; Male; Protein Binding; Transferrin

1991
Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain.
    Lancet (London, England), 1990, Mar-31, Volume: 335, Issue:8692

    Topics: Adult; Aged; Aluminum; Alzheimer Disease; Binding Sites; Brain; Dementia, Vascular; Down Syndrome; Evaluation Studies as Topic; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Renal Dialysis; Transferrin

1990
Gallium-transferrin binding in Alzheimer disease.
    Lancet (London, England), 1990, Jun-02, Volume: 335, Issue:8701

    Topics: Aluminum; Alzheimer Disease; Brain; Down Syndrome; Gallium; Humans; Receptors, Transferrin; Transferrin

1990
Gallium-transferrin binding in Alzheimer's disease.
    Lancet (London, England), 1990, Sep-08, Volume: 336, Issue:8715

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Proteins; Female; Gallium; Humans; Male; Transferrin

1990
Gallium-67 as a potential marker for aluminium transport in rat brain: implications for Alzheimer's disease.
    Journal of neurochemistry, 1990, Volume: 55, Issue:1

    Topics: Aluminum; Alzheimer Disease; Animals; Autoradiography; Blood-Brain Barrier; Brain; Capillary Permeability; Gallium; Gallium Radioisotopes; Male; Proteins; Rats; Rats, Inbred Strains; Tissue Distribution; Transferrin

1990
Aluminium chelator (transferrin) reverses biochemical deficiency in Alzheimer brain preparations.
    Lancet (London, England), 1989, Jan-14, Volume: 1, Issue:8629

    Topics: Acetates; Alzheimer Disease; Biopterins; Brain; Chelating Agents; Humans; Transferrin

1989
Lipid peroxidation and free radical scavengers in Alzheimer's disease.
    Gerontology, 1989, Volume: 35, Issue:5-6

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Ascorbic Acid; Ceruloplasmin; Copper; Female; Free Radicals; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Nutritional Status; Selenium; Serum Albumin; Superoxide Dismutase; Transferrin; Vitamin A; Vitamin E; Zinc

1989
Changes in brain gene expression shared by scrapie and Alzheimer disease.
    Proceedings of the National Academy of Sciences of the United States of America, 1989, Volume: 86, Issue:18

    Topics: Alzheimer Disease; Animals; Base Sequence; Brain; Clusterin; Cricetinae; Genes; Glial Fibrillary Acidic Protein; Glycoproteins; Metallothionein; Molecular Chaperones; Molecular Sequence Data; Nerve Tissue Proteins; Rats; RNA, Messenger; Scrapie; Sequence Homology, Nucleic Acid; Transcription, Genetic; Transferrin

1989
Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer's disease and multi-infarct dementia.
    European neurology, 1987, Volume: 26, Issue:4

    Topics: Aged; Aged, 80 and over; Albumins; Alzheimer Disease; Blood Proteins; Blood-Brain Barrier; Cerebrospinal Fluid Proteins; Dementia; Female; Haptoglobins; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; Transferrin

1987
CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis.
    Journal of the neurological sciences, 1985, Volume: 70, Issue:1

    Topics: Aged; Alzheimer Disease; Blood Proteins; Blood-Brain Barrier; Cerebrospinal Fluid Proteins; Female; Haptoglobins; Humans; Immunoglobulin G; Male; Middle Aged; Transferrin

1985